Literature DB >> 19380790

Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity.

Timothy W Phares1, Chandran Ramakrishna, Gabriel I Parra, Alan Epstein, Lieping Chen, Roscoe Atkinson, Stephen A Stohlman, Cornelia C Bergmann.   

Abstract

The neurotropic coronavirus JHM strain of mouse hepatitis virus persists in oligodendroglia despite the presence of virus-specific CD8 T cells. Expression of programmed death 1 (PD-1) and B7-H1 were studied during acute and persistent infection to examine whether this negative regulatory mechanism contributes to CNS viral persistence. The majority of CNS-infiltrating CD8 T cells expressed PD-1, with the highest levels on virus-specific CD8 T cells. Moreover, despite control of infectious virus, CD8 T cells within the CNS of persistently infected mice maintained high PD-1 expression. Analysis of virus-susceptible target cells in vivo revealed that B7-H1 expression was regulated in a cell type-dependent manner. Oligodendroglia and microglia up-regulated B7-H1 following infection; however, although B7-H1 expression on oligodendroglia was prominent and sustained, it was significantly reduced and transient on microglia. Infection of mice deficient in the IFN-gamma or IFN-alpha/beta receptor demonstrated that B7-H1 expression on oligodendroglia is predominantly regulated by IFN-gamma. Ab blockade of B7-H1 on oligodendroglia in vitro enhanced IFN-gamma secretion by virus-specific CD8 T cells. More efficient virus control within the CNS of B7-H1-deficient mice confirmed inhibition of CD8 T cell function in vivo. Nevertheless, the absence of B7-H1 significantly increased morbidity without altering demyelination. These data are the first to demonstrate glia cell type-dependent B7-H1 regulation in vivo, resulting in adverse effects on antiviral CD8 T cell function. However, the beneficial role of PD-1:B7-H1 interactions in limiting morbidity highlights the need to evaluate tissue-specific intervention strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380790      PMCID: PMC2909606          DOI: 10.4049/jimmunol.0803557

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

Review 1.  Molecular and cellular permeability control at the blood-brain barrier.

Authors:  S M Gloor; M Wachtel; M F Bolliger; H Ishihara; R Landmann; K Frei
Journal:  Brain Res Brain Res Rev       Date:  2001-10

Review 2.  MHV infection of the CNS: mechanisms of immune-mediated control.

Authors:  N W Marten; S A Stohlman; C C Bergmann
Journal:  Viral Immunol       Date:  2001       Impact factor: 2.257

3.  Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein.

Authors:  B Fuss; B Mallon; T Phan; C Ohlemeyer; F Kirchhoff; A Nishiyama; W B Macklin
Journal:  Dev Biol       Date:  2000-02-15       Impact factor: 3.582

4.  PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy.

Authors:  U Sester; D Presser; J Dirks; B C Gärtner; H Köhler; M Sester
Journal:  Am J Transplant       Date:  2008-07       Impact factor: 8.086

5.  In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection.

Authors:  J M Redwine; M J Buchmeier; C F Evans
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

6.  Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia.

Authors:  Jessica K Roth-Cross; Susan J Bender; Susan R Weiss
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

7.  Interaction of human PD-L1 and B7-1.

Authors:  Manish J Butte; Victor Peña-Cruz; Mi-Jung Kim; Gordon J Freeman; Arlene H Sharpe
Journal:  Mol Immunol       Date:  2008-06-27       Impact factor: 4.407

8.  Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis.

Authors:  Nancy Rodig; Timothy Ryan; Jessica A Allen; Hong Pang; Nir Grabie; Tatyana Chernova; Edward A Greenfield; Spencer C Liang; Arlene H Sharpe; Andrew H Lichtman; Gordon J Freeman
Journal:  Eur J Immunol       Date:  2003-11       Impact factor: 5.532

Review 9.  PD-1 and its ligands in tolerance and immunity.

Authors:  Mary E Keir; Manish J Butte; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

10.  Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis.

Authors:  Monique Lafon; Françoise Mégret; Sven G Meuth; Ole Simon; Myriam L Velandia Romero; Mireille Lafage; Lieping Chen; Lena Alexopoulou; Richard A Flavell; Christophe Prehaud; Heinz Wiendl
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

View more
  51 in total

1.  Acute Viral Respiratory Infection Rapidly Induces a CD8+ T Cell Exhaustion-like Phenotype.

Authors:  John J Erickson; Pengcheng Lu; Sherry Wen; Andrew K Hastings; Pavlo Gilchuk; Sebastian Joyce; Yu Shyr; John V Williams
Journal:  J Immunol       Date:  2015-09-23       Impact factor: 5.422

2.  Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis.

Authors:  Timothy W Phares; Stephen A Stohlman; David R Hinton; Roscoe Atkinson; Cornelia C Bergmann
Journal:  J Immunol       Date:  2010-09-27       Impact factor: 5.422

3.  PD-L1/B7-H1 regulates the survival but not the function of CD8+ T cells in herpes simplex virus type 1 latently infected trigeminal ganglia.

Authors:  Sohyun Jeon; Anthony J St Leger; Thomas L Cherpes; Brian S Sheridan; Robert L Hendricks
Journal:  J Immunol       Date:  2013-05-08       Impact factor: 5.422

4.  CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis.

Authors:  Cristina P Marques; Parul Kapil; David R Hinton; Claudia Hindinger; Stephen L Nutt; Richard M Ransohoff; Timothy W Phares; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

5.  Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke.

Authors:  Xuefang Ren; Kozaburo Akiyoshi; Arthur A Vandenbark; Patricia D Hurn; Halina Offner
Journal:  Stroke       Date:  2011-07-07       Impact factor: 7.914

6.  Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.

Authors:  Purevdorj B Olkhanud; Bazarragchaa Damdinsuren; Monica Bodogai; Ronald E Gress; Ranjan Sen; Katarzyna Wejksza; Enkhzol Malchinkhuu; Robert P Wersto; Arya Biragyn
Journal:  Cancer Res       Date:  2011-03-28       Impact factor: 12.701

Review 7.  Immune Surveillance of the CNS following Infection and Injury.

Authors:  Matthew V Russo; Dorian B McGavern
Journal:  Trends Immunol       Date:  2015-10       Impact factor: 16.687

8.  CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis.

Authors:  Timothy W Phares; Stephen A Stohlman; Mihyun Hwang; Booki Min; David R Hinton; Cornelia C Bergmann
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

9.  Ifit2 deficiency results in uncontrolled neurotropic coronavirus replication and enhanced encephalitis via impaired alpha/beta interferon induction in macrophages.

Authors:  Niranjan B Butchi; David R Hinton; Stephen A Stohlman; Parul Kapil; Volker Fensterl; Ganes C Sen; Cornelia C Bergmann
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

10.  The role of interleukin-6 in the expression of PD-1 and PDL-1 on central nervous system cells following infection with Theiler's murine encephalomyelitis virus.

Authors:  Young-Hee Jin; Wanqiu Hou; Hyun Seok Kang; Chang-Sung Koh; Byung S Kim
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.